In contrast, in the Gli-1-null or cytoplasmic expression or no residual tumour group (n=62), recurrences were found in 22 patients (in the liver, bone, lung, neck lymph nodes, and thyroid gland). The gene discussed is GLI1; the disease is neoplasm.